Posted by Michael Wonder on 07 Mar 2023
PHARMAC announces decision to fund Trikafta
7 March 2023 - Pharmac has today confirmed the funding of elexacaftor with tezacaftor and ivacaftor (Trikafta) for people with cystic fibrosis, aged 6 years and above, who meet certain eligibility criteria.
Trikafta will be listed on the Pharmaceutical Schedule from 1 April 2023, subject to eligibility criteria.
